RESUMO
Laboratory studies have shown that the nonindigenous Asian shore crab, Hemigrapsus sanguineus, readily consumes three species of commercial bivalves: blue mussels, Mytilus edulis, soft-shell clams, Mya arenaria, and oysters, Crassostrea virginica. Although crabs can eat bivalves of a wide size range, they preferred the smaller prey (=10 mm SL). Prey critical size limits exist for M. edulis and C. virginica, but not M. arenaria, possibly because of differences in shell characteristics among the three species. Crabs preferred M. arenaria over both M. edulis and C. virginica, and M. edulis was strongly preferred over C. virginica in pairwise comparison tests. Experiments to determine feeding rates on mussels showed that H. sanguineus can consume large numbers of mussels daily (12.7+/-11.6 mussels day(-1); sexes pooled; N=59). Mussel consumption rates increased with size of the predator and male crabs consumed more mussels than did similarly sized female crabs. The high densities of Hemigrapsus that occur in the wild, their effectiveness as predators of juvenile bivalves and their large appetites suggest an important role for these predators in restructuring the prey communities in habitats into which they have been introduced.
RESUMO
The results of a 6-month mark and recapture experiment involving approximately 900 adult Mya arenaria demonstrated that under natural conditions, significantly higher (P much less than .001, chi 2 test) mortality occurred among animals with neoplasia than those diagnosed as normal. Using a blood screening technique, the clams were diagnosed and placed in one of three diagnostic groups based on the severity of the disease (the percentage neoplastic cells per total number of blood cells): Nonneoplastic (NN), 0%; low severity neoplastic (LSN), less than 50%; and high severity neoplastic (HSN), greater than 50%. Fifty-one percent of those clams initially diagnosed as HSN died by the end of the test period as compared to 8% of the LSN clams and only 3% of the normals. Both progression and remission of the disease were also evident. Approximately 10% of the clams in the NN and LSN groups progressed to a LSN or HSN condition, whereas 16% of those clams initially identified as LSN, and that were recovered alive, underwent complete remission during the test period. Comparison of the field results with those of an 18-week laboratory study suggests that studies of mortality done under laboratory conditions may not provide useful data for the interpretation of the quantitative effects of a disease process, such as molluscan neoplasia, on the natural population of the animal studied.